Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Capital Employed (2022 - 2025)

Atara Biotherapeutics' Return on Capital Employed history spans 4 years, with the latest figure at 0.67% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 895.0% year-over-year to 0.67%; the TTM value through Dec 2025 reached 0.67%, down 895.0%, while the annual FY2025 figure was 0.14%, 3074.0% up from the prior year.
  • Return on Capital Employed reached 0.67% in Q4 2025 per ATRA's latest filing, down from 1.69% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 25.62% in Q2 2024 to a low of 7.9% in Q4 2023.
  • Average Return on Capital Employed over 4 years is 3.4%, with a median of 0.23% recorded in 2025.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 2715bps in 2024, then tumbled -2539bps in 2025.
  • A 4-year view of Return on Capital Employed shows it stood at 0.96% in 2022, then plummeted by -727bps to 7.9% in 2023, then skyrocketed by 222bps to 9.62% in 2024, then tumbled by -93bps to 0.67% in 2025.
  • Per Business Quant, the three most recent readings for ATRA's Return on Capital Employed are 0.67% (Q4 2025), 1.69% (Q3 2025), and 0.23% (Q2 2025).